325 related articles for article (PubMed ID: 30842242)
41. Update on Recurrent Respiratory Papillomatosis.
Derkay CS; Bluher AE
Otolaryngol Clin North Am; 2019 Aug; 52(4):669-679. PubMed ID: 31078306
[TBL] [Abstract][Full Text] [Related]
42. Altered Monocyte and Langerhans Cell Innate Immunity in Patients With Recurrent Respiratory Papillomatosis (RRP).
Israr M; DeVoti JA; Lam F; Abramson AL; Steinberg BM; Bonagura VR
Front Immunol; 2020; 11():336. PubMed ID: 32210959
[TBL] [Abstract][Full Text] [Related]
43. Treatment of Recurrent Respiratory Papillomatosis: Case Series and Review of Technique.
Manley C; Hutchinson C; Mahajan A; Ibrahim O; Folch E; Kumar R
Surg Technol Int; 2021 May; 38():139-143. PubMed ID: 33844241
[TBL] [Abstract][Full Text] [Related]
44. Durable Response to Nivolumab in a Pediatric Patient with Refractory Glioblastoma and Constitutional Biallelic Mismatch Repair Deficiency.
AlHarbi M; Ali Mobark N; AlMubarak L; Aljelaify R; AlSaeed M; Almutairi A; Alqubaishi F; Hussain ME; Balbaid AAO; Said Marie A; AlSubaie L; AlShieban S; alTassan N; Ramkissoon SH; Abedalthagafi M
Oncologist; 2018 Dec; 23(12):1401-1406. PubMed ID: 30104292
[TBL] [Abstract][Full Text] [Related]
45. Lung squamous cell carcinoma arising in a patient with adult-onset recurrent respiratory papillomatosis.
Hasegawa Y; Sato N; Niikawa H; Kamata S; Sannohe S; Kurotaki H; Sasaki T; Ebina A
Jpn J Clin Oncol; 2013 Jan; 43(1):78-82. PubMed ID: 23110763
[TBL] [Abstract][Full Text] [Related]
46. Recurrent respiratory papillomatosis in northern Sweden: clinical characteristics and practical guidance.
Loizou C; Laurell G; Arvidsson A; Lindquist D; Nylander K; Olofsson K
Acta Otolaryngol; 2015; 135(10):1058-64. PubMed ID: 26004132
[TBL] [Abstract][Full Text] [Related]
47. Prolonged Response to Anti-PD-1 Antibody Therapy in Chemotherapy-Refractory Cholangiocarcinoma With High Tumor Mutational Burden.
Gbolahan O; Hashemi-Sadraei N; O'Neil B
J Natl Compr Canc Netw; 2019 Jun; 17(6):644-648. PubMed ID: 31200359
[TBL] [Abstract][Full Text] [Related]
48. A rationale for surgical debulking to improve anti-PD1 therapy outcome in non small cell lung cancer.
Guisier F; Cousse S; Jeanvoine M; Thiberville L; Salaun M
Sci Rep; 2019 Nov; 9(1):16902. PubMed ID: 31729430
[TBL] [Abstract][Full Text] [Related]
49. Squamous Cell Papillomatosis in the Setting of Recurrent Respiratory Papillomatosis.
Bentley PL; Coulter MJ; Nelson BL
Head Neck Pathol; 2019 Jun; 13(2):235-238. PubMed ID: 29594918
[TBL] [Abstract][Full Text] [Related]
50. Clinical implications of monitoring nivolumab immunokinetics in non-small cell lung cancer patients.
Osa A; Uenami T; Koyama S; Fujimoto K; Okuzaki D; Takimoto T; Hirata H; Yano Y; Yokota S; Kinehara Y; Naito Y; Otsuka T; Kanazu M; Kuroyama M; Hamaguchi M; Koba T; Futami Y; Ishijima M; Suga Y; Akazawa Y; Machiyama H; Iwahori K; Takamatsu H; Nagatomo I; Takeda Y; Kida H; Akbay EA; Hammerman PS; Wong KK; Dranoff G; Mori M; Kijima T; Kumanogoh A
JCI Insight; 2018 Oct; 3(19):. PubMed ID: 30282824
[TBL] [Abstract][Full Text] [Related]
51. Novel treatments for recurrent respiratory papillomatosis.
Armbruster C
Expert Opin Investig Drugs; 2002 Aug; 11(8):1139-48. PubMed ID: 12150707
[TBL] [Abstract][Full Text] [Related]
52. Malignant transformation of a highly aggressive human papillomavirus type 11-associated recurrent respiratory papillomatosis.
Lin HW; Richmon JD; Emerick KS; de Venecia RK; Zeitels SM; Faquin WC; Lin DT
Am J Otolaryngol; 2010; 31(4):291-6. PubMed ID: 20015762
[TBL] [Abstract][Full Text] [Related]
53. Human papilloma virus (HPV)-associated gynecological alteration in mothers of children with recurrent respiratory papillomatosis during long-term observation.
Gerein V; Schmandt S; Babkina N; Barysik N; Coerdt W; Pfister H
Cancer Detect Prev; 2007; 31(4):276-81. PubMed ID: 17935912
[TBL] [Abstract][Full Text] [Related]
54. Nivolumab in the treatment of microsatellite instability high metastatic colorectal cancer.
Mehrvarz Sarshekeh A; Overman MJ; Kopetz S
Future Oncol; 2018 Aug; 14(18):1869-1874. PubMed ID: 29473436
[TBL] [Abstract][Full Text] [Related]
55. The predominant site of pharyngeal lesions in patients with recurrent respiratory papillomatosis.
Matsuzaki H; Asai R; Makiyama K
Eur Arch Otorhinolaryngol; 2022 Sep; 279(9):4461-4464. PubMed ID: 35503132
[TBL] [Abstract][Full Text] [Related]
56. Metastatic squamous-cell carcinoma of the lung arising in a 12-year-old boy with juvenile recurrent respiratory papillomatosis of neonatal onset.
Boudjemaa S; Leboulanger N; Daınese L; Cremoux PD; Pointe HD; Coulomb A
Turk Patoloji Derg; 2014; 30(2):133-6. PubMed ID: 24638196
[TBL] [Abstract][Full Text] [Related]
57. Long-term Outcomes of Juvenile Onset Recurrent Respiratory Papillomatosis with Pulmonary Involvement.
Yang Q; Li Y; Ma L; Xiao Y; Wang H; Ding Y; Hu R; Wang X; Meng L; Wang J; Xu W
Laryngoscope; 2021 Jul; 131(7):EE2277-E2283. PubMed ID: 33411979
[TBL] [Abstract][Full Text] [Related]
58. Parenteral Bevacizumab for the Treatment of Severe Respiratory Papillomatosis in an Adult Population.
Tkaczuk A; Trivedi S; Mody MD; Steuer CE; Shin DM; Klein AM; Saba NF
Laryngoscope; 2021 Mar; 131(3):E921-E928. PubMed ID: 33107615
[TBL] [Abstract][Full Text] [Related]
59. Novel human papilloma virus (HPV) genotypes in children with recurrent respiratory papillomatosis.
Mammas IN; Sourvinos G; Vakonaki E; Giamarelou P; Michael C; Spandidos DA
Eur J Pediatr; 2010 Aug; 169(8):1017-21. PubMed ID: 20213305
[TBL] [Abstract][Full Text] [Related]
60. Lower airway papillomatosis in children.
Zawadzka-Głos L; Jakubowska A; Chmielik M; Bielicka A; Brzewski M
Int J Pediatr Otorhinolaryngol; 2003 Oct; 67(10):1117-21. PubMed ID: 14550967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
